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Abstract
Background
Immune-mediated haemolytic anaemia (IMHA) is reported to be the most common autoim-
mune disease of dogs, resulting in significant morbidity and mortality in affected animals.
Haemolysis is caused by the action of autoantibodies, but the immunological changes that
result in their production have not been elucidated.
Aims
To investigate the frequency of regulatory T cells (Tregs) and other lymphocyte subsets and
to measure serum concentrations of cytokines and peripheral blood mononuclear cell
expression of cytokine genes in dogs with IMHA, healthy dogs and dogs with inflammatory
diseases.
Animals
19 dogs with primary IMHA, 22 dogs with inflammatory diseases and 32 healthy control
dogs.
Methods
Residual EDTA-anti-coagulated blood samples were stained with fluorophore-conjugated
monoclonal antibodies and analysed by flow cytometry to identify Tregs and other lympho-
cyte subsets. Total RNA was also extracted from peripheral blood mononuclear cells to
investigate cytokine gene expression, and concentrations of serum cytokines (interleukins
2, 6 10, CXCL-8 and tumour necrosis factor α) were measured using enhanced chemilumi-
nescent assays. Principal component analysis was used to investigate latent variables that
might explain variability in the entire dataset.
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Results
There was no difference in the frequency or absolute numbers of Tregs among groups, nor
in the proportions of other lymphocyte subsets. The concentrations of pro-inflammatory
cytokines were greater in dogs with IMHA compared to healthy controls, but the concentra-
tion of IL-10 and the expression of cytokine genes did not differ between groups. Principal
component analysis identified four components that explained the majority of the variability
in the dataset, which seemed to correspond to different aspects of the immune response.
Conclusions
The immunophenotype of dogs with IMHA differed from that of dogs with inflammatory dis-
eases and from healthy control dogs; some of these changes could suggest abnormalities in
peripheral tolerance that permit development of autoimmune disease. The frequency of
Tregs did not differ between groups, suggesting that deficiency in the number of these cells
is not responsible for development of IMHA.
Introduction
Immune-mediated haemolytic anaemia (IMHA) is considered to be the most common auto-
immune disease of dogs and typically results in severe anaemia that develops acutely [1].
Development of IMHA in dogs is related to production of antibodies specific for normal mole-
cules on the surface of erythrocytes. These antibodies cause activation of the complement cas-
cade, resulting in intravascular lysis of red blood cells, or they opsonise red blood cells to
facilitate phagocytosis by cells of the monocyte phagocyte system (MPS) in the liver and spleen
[2]. Previous studies of dogs with IMHA indicate that autoantibodies and autoreactive T cells
are most commonly specific for epitopes on glycophorin molecules expressed on the surface of
red blood cells, but patterns of reactivity are not consistent among individual dogs [3,4].
Production of autoantibodies indicates failure of peripheral immune tolerance, a complex
network of humoral and cellular factors that normally prevent T cells emigrating from the thy-
mus from mounting responses against normal host tissues [5]. Regulatory T cells (Tregs)
derived from the thymus represent one of the factors that contributes to maintenance of
peripheral tolerance: these cells are recognised in mice, people and various domestic species,
including dogs, by expression of the transcription factor FoxP3, expression of CD4 and consti-
tutive display of the interleukin(IL)-2 receptor alpha chain (CD25) [6–8]. Regulatory T cells
have the ability to suppress the activity of conventional T cells, B cells and cells of the innate
immune system by various mechanisms, including the production of cytokines (such as IL-10
and transforming growth factor beta, TGFβ), surface expression of inhibitory molecules (such
as cytotoxic T lymphocyte antigen (CTLA)-4) [9], and direct lysis or metabolic disruption of
target cells [6].
Soluble signalling molecules, including cytokines, are also likely to contribute to mainte-
nance of peripheral tolerance but their exact role has proved difficult to define because their
effects are dependent on immune context. These cytokines also permit integration of Treg
activity with other components of the immune system that have regulatory activity. Overpro-
duction of the pro-inflammatory cytokines IL-6 and tumour necrosis factor alpha (TNFα) has
been associated with disease activity in models of human autoimmune disease; this could be
related to their ability to decrease the suppressive activity of Tregs [10,11]. Conversely, IL-2
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and 10 are required to maintain the size and activity of the normal Treg compartment in mice
[12,13], such that animals with experimental deficiencies in either molecule develop spontane-
ous autoimmune diseases [14,15].
Greater understanding of abnormalities in peripheral immune tolerance in dogs with
IMHA may guide future attempts to produce therapeutic agents that might control the auto-
immune response [16]. This approach has been fructiferous in people, in whom recombinant
monoclonal antibodies against TNFα and CD20 (a molecule exclusively expressed on the sur-
face of B cells) are employed in treatment of warm autoimmune haemolytic anaemia
(wAIHA) [17], a disease that closely resembles IMHA in dogs.
In this project, we hypothesised that the immune phenotype of dogs with IMHA would dif-
fer from that of healthy dogs or dogs with inflammatory diseases without autoimmune aetiol-
ogy, revealing defects in peripheral immune tolerance in the former group. Specifically, we
hypothesised that dogs with IMHA would have a decreased frequency of circulating Tregs and
lower serum concentrations of IL-10 but higher concentrations of pro-inflammatory cytokines
than the control dogs in other groups.
Materials and Methods
Identification of cases and collection of samples
Three groups of dogs were recruited to the study over a period of 28 months, from July 2013 to
January 2016: healthy control dogs (HC), dogs with inflammatory diseases (INF) and dogs
with primary IMHA (IMHA). Samples were collected from healthy dogs belonging to staff and
students at the study institution under license from the Animals (Scientific Procedures) Act
1986. None of these dogs had a history of autoimmune disease; physical examination was
unremarkable in all cases.
Dogs in the INF group were recruited after they were diagnosed with an inflammatory dis-
ease that was not considered to have an immune-mediated aetiology. None of these dogs had a
history of previous autoimmune disease, and all were followed until the conclusion of the
study (in January 2016) to ensure that their clinical signs were not ultimately ascribed to auto-
immune disease. All dogs in this group underwent diagnostic testing, including a complete
blood cell count (CBC), serum biochemical profile and imaging of the thorax and abdomen,
with additional tests selected by the attending veterinarian as considered appropriate. Dogs
were excluded from this group if they were diagnosed with or had a previous history of auto-
immune disease, or if a likely diagnosis could not be established.
Dogs were diagnosed with IMHA if they were anaemic (with a packed cell volume of less
than 35%) and fulfilled at least one of the following criteria that suggested the presence of anti-
bodies specific for erythrocytes: persistent microscopic or macroscopic agglutination of blood
after dilution in saline, titre greater than or equal to 1:16 in a direct anti-globulin test (DAT,
Coombs’ test), or presence of spherocytes on assessment of a fresh blood smear by a board cer-
tified veterinary clinical pathologist. Agglutination of blood was assessed by mixing one drop
of EDTA-anticoagulated blood with one drop of 0.9% saline on a glass slide before macro-
scopic and microscopic inspection. Dogs were excluded from this group if they had previously
been diagnosed with IMHA (and were suffering a relapse of the same disease), or if any under-
lying cause of immune-mediated disease was suspected from perusal of the clinical history,
physical examination findings or results of the CBC, serum biochemical profile, serological
tests for vector-borne infectious agents, imaging of the thorax and abdomen, and any other
tests that were considered appropriate by the attending clinician. Dogs were also excluded if
they had received immunosuppressive drugs prior to presentation at the study institution, or if
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they had received xenobiotic drugs (apart from routine anthelmintic or ectoparasiticidal treat-
ment) or vaccines in the two week period prior to the onset of clinical signs.
Complete blood cell counts for dogs in the IMHA and INF groups were generated using the
ADVIA 120 analyser (Siemens), and fresh blood smears were evaluated by a veterinary clinical
pathologist in all cases. Serum biochemical profiles were produced with an ILAB 600 analyser
(Instrumentation Laboratory).
Owners of all dogs were required to give informed consent for participation of their animal
in the study, and the study had received approval from the Royal Veterinary College Clinical
Research Ethical Review Board (reference number 2011_1134). Residual serum samples and
residual samples of EDTA-anticoagulated blood were collected from the laboratory in which
diagnostic samples had been analysed, though, in some cases, only one type of sample was
available.
Flow cytometry
Samples of EDTA-anticoagulated blood (volume 0.5 to 1.3 ml) were lysed using a buffer made
by mixing 4.15 g ammonium chloride (VWR International), 18.5 mg disodium EDTA
(SIGMA), and 0.5 g potassium bicarbonate (Sigma Aldrich) with 500 ml distilled water,
adjusted to pH 7.4 and stored at 4˚C. The blood sample was mixed with 10 ml of the lysis
buffer and incubated at room temperature for seven minutes, then washed and re-suspended
in phosphate-buffered saline (PBS) with 10% fetal calf serum (Biosera). The remaining periph-
eral blood mononuclear cells (PBMCs) were stained with fluorophore-conjugated antibodies
specific for surface molecules (CD4, CD5 and CD8) and incubated at 4˚C for 30 minutes, then
washed and incubated in a fixation/permeabilisation buffer for 12 to 18 hours at 4˚C in the
dark, according to the manufacturers’ instructions (Foxp3/Transcription Factor Staining
Buffer Set, Affymetrix eBioscience). The PBMCs were then stained with antibodies specific for
intracellular molecules (CD79b and FoxP3). The antibody clones used in these experiments
are shown in S1 Table. Cell staining was assessed by flow cytometry using a FACS Canto II
cytometer (BD), and results were analysed using commercially available software (FlowJo,
Treestar).
Reverse transcription-polymerase chain reactions
Quantitative polymerase chain reactions were performed according to published guidelines
[18]. Samples of EDTA-anticoagulated blood were added to a pre-mixed RNA stabilising solu-
tion (RiboPure RNA Purification kit—blood, ThermoFisher Scientific) and then stored at
-80˚C until further analysis was completed. Ribonucleic acid was extracted from PBMCs
according to the manufacturer’s instructions, and genomic DNA was degraded using the
DNase I provided. The concentration and purity of the RNA were determined by measure-
ment of absorbance of light at wavelengths of 260 nm and 280 nm (NanoDrop ND-1000,
Thermo Scientific).
Three reference genes were selected based on the stability of their expression in samples
from dogs in the HC group (n = 5) and IMHA group (n = 5), as determined using a commer-
cially available kit and associated software (geNorm Reference Gene Selection Kit with Double
Dye (Hydrolysis) probe, with qBase+ software and 2x PrecisionPLUS Mastermix, Primerde-
sign). The reference genes selected were b2m, sdha and rpl32, with primers shown in S2 Table.
Relative expression of the genes of interest, il10 and ifng, was determined by reverse tran-
scriptase quantitative PCR, using the primers shown in S2 Table. All primers were obtained
from Thermo Fisher Scientific. Each reaction well in a black 384 well plate (Bio-Rad) con-
tained the primers (at a final concentration of 900 nM), fam probe (at 250 nM), a one-step
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reverse transcriptase and DNA polymerase enzyme solution (Precision Onestep qRT-PCR
Mastermix, Primerdesign, 10 μl per well), and 25 ng of RNA in a total volume of 20 μl. The
reaction plate was incubated at 55˚C for 15 minutes to allow reverse transcription, before the
DNA polymerase was activated by incubation at 95˚C for 8 minutes. The plate then underwent
40 cycles of denaturation (95˚C for 10 seconds) and extension with data collection (60˚C for
60 seconds), all using a CFX 384 Real-Time PCR detection system (Bio-Rad).
Expression of each gene was assessed in duplicate for each dog. The relative expression of
each gene was then quantified using Eq 1, where AE refers to the geometric mean of the ampli-
fication efficiency values for the reference genes and the gene of interest, and Cq refers to the
cycle in which fluorescence was first detected. Amplification efficiency values were calculated
from five point standard curves constructed for each set of primers using Eq 2.
Relative expression ¼ ðAEÞðCq½gene of interest  Cq½geometric mean of reference genesÞ ð1Þ
Amplification Efficiency ¼ 10ð 
1
slopeÞ ð2Þ
Cytokine measurements
Serum samples were collected and stored in plain polyethylene tubes (Greiner Bio-one) at
-80˚C until further analyses were completed. The serum concentrations of IL-2, 6 and 10,
TNFα and CXCL8 were measured using enhanced chemiluminescent assays (Canine Proin-
flammatory Panel 3 Ultra-Sensitive Kit and Canine IL-10 Assay Ultra-Sensitive Kit, Meso
Scale Discovery), as described previously in dogs [19]. Chemiluminescence was measured
using a SECTOR S 600 instrument (Meso Scale Discovery). Cytokine measurements were
made in duplicate for each dog, and individual values were calculated after fitting a standard
curve using four-parameter logistic regression, with 1/Y2 weighting.
Statistical analysis
Analyses were conducted using statistical software packages (SPSS version 21, IBM and Graph-
Pad Prism version 6, GraphPad Software). Variables were assessed for normality by visual
inspection of histograms and using the Shapiro-Wilks test. Non-parametric variables were
compared using the Mann-Whitney U test and Kruskal-Wallis test, whereas normally distrib-
uted variables were compared with the Student’s t test. Categorical variables were compared
using the Chi squared test or Fisher’s exact test, depending on the number of cases per cell.
The nature of the underlying variability in the set of immunological and haematological
variables was explored by principal component analysis with varimax rotation, using INF
(n = 10) and IMHA (n = 6) dogs that had a complete set of data available. Components were
extracted if they had eigenvalues greater than 1; scores were calculated for each animal for
each component by regression, and these were then compared between groups.
The manuscript was presented according to the STROBE statement for standardised
reporting of observational studies [20]. All data obtained in this study are available in S1 File.
Results
Recruitment of cases
We collected samples from 32 dogs with IMHA, of which 12 were excluded because they had
received immunosuppressive treatment prior to presentation to our institution. One further
dog was excluded because it was suffering a relapse of the disease and had undergone
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splenectomy previously. The remaining dogs had a median age of 8.0 years (inter-quartile
range [IQR]: 3.9–9.6) and included one entire male, 9 castrated males, one entire female and 8
neutered females. Ten different breeds were represented, of which the most frequent were
cocker spaniels (n = 4), English Springer spaniels (n = 3), Labrador retrievers (n = 3), and
cross-breed dogs (n = 4) (Table 1). Diagnosis of IMHA was based on confirmation of anaemia
in all cases (median packed cell volume 15.0%, IQR: 10.5–17.5, range: 5.0–29.0) and the pres-
ence of spherocytes on a blood smear (n = 15, 78.9%), or continued agglutination after dilution
in saline (n = 14, 73.7%), or a titre of1:16 in the DAT (n = 2, 10.5%).
Samples were also obtained from 26 dogs with inflammatory diseases, of which two were
excluded because they were presumptively diagnosed with immune-mediated diseases (sterile
lympadenitis in one dog and immune-mediated polyarthritis in the other), and two others
were excluded because they were diagnosed with cancer (lymphoma in one dog and haeman-
giosarcoma in the other). The median age of the 22 dogs that were included was 5.0 years
(IQR: 2.6–7.0), with sex distribution shown in Table 1. The final diagnoses for dogs in this
group included acute onset diarrhoea and/or vomiting (n = 6), pancreatitis (4), aspiration
pneumonia (2), leptospirosis (2), bacterial endocarditis (1), chronic hepatitis (1), idiopathic
haemorrhagic diarrhoea syndrome (1), prostatitis (1), retrobulbar cellulitis (1), urinary tract
infection (1), and oesophageal stricture (1).
Thirty-one healthy dogs were included in the study, for which the median age was 5.7 years
(IQR: 4.0–7.0). There was no difference in age between the three groups (Kruskal-Wallis test,
p = 0.174), nor in the proportion of male and female dogs (Pearson Chi squared, p = 0.498).
Frequency of regulatory T cells was similar among groups
To test our hypothesis that the frequency of regulatory T cells is reduced in dogs with IMHA
compared to healthy dogs and those with inflammatory diseases, we performed flow cyto-
metric analysis of PBMCs after lysis of red blood cells. We identified regulatory T cells using
Table 1. Demographic characteristics of the three groups of dogs recruited to this study.
Group IMHAa INFb HCc
N 19 22 31
Age (years)
Median 8.0 5 5.7
IQRd 3.9–9.6 2.6–7.0 4.0–7.0
Sex (N)
Male entire 1 7 3
Male
neutered
9 5 10
Female
entire
1 3 1
Female
neutered
8 7 17
Breed (N, four
most frequent)
Cocker spaniel (n = 4), English
springer spaniel (3), cross breed (3),
Labrador retriever (3)
Cross breed (n = 3), English springer
spaniel (3), Dachshund (2), Labrador
retriever (2)
Cross breed (n = 6), Labrador retriever
(6), Staffordshire bull terrier (2),
greyhound(2)
a: healthy control;
b: inflammatory disease;
c: immune-mediated haemolytic anaemia;
d: inter-quartile range.
doi:10.1371/journal.pone.0168296.t001
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the cascaded gating strategy outlined in Fig 1A, where a population of lymphocytes was
selected sequentially based on its expression of CD5, CD4 and FoxP3. The median frequency
of FoxP3+ T cells (expressed as a percentage of the CD4+CD5hi population and taken as Tregs)
was 4.2% (IQR: 1.6–7.5, n = 10) in the IMHA group, 3.0% (IQR: 2.4–4.4, n = 15) in the INF
group, and 4.2% (IQR: 3.4–5.8, n = 30) in healthy dogs, with no significant difference between
groups (Kruskal-Wallis, p = 0.180). The frequencies of CD4+ T cells (p = 0.965) and CD8+ T
cells (p = 0.258) were also similar among groups (Fig 1).
IMHA was associated with increased production of pro-inflammatory
cytokines
Next, we explored the hypothesis that development of IMHA in dogs is associated with an
imbalance between cytokines that have largely pro- and anti-inflammatory effects. We found
that cytokines with a pro-inflammatory effect (IL-2, IL-6, CXCL-8 and TNFα) were present in
the serum of dogs with IMHA at significantly greater concentrations than in the HC group
(Fig 2A–2D). Interestingly, the concentration of TNFα was greater in the IMHA group than
INF group, and greater in the INF group than the HC group, suggesting that development of
IMHA is associated with a stronger inflammatory response than in diseases that were not of
autoimmune aetiology. Conversely, the concentration of IL-10, which usually exerts a broadly
anti-inflammatory effect, was similar among the three groups (Fig 2E). We also examined the
expression of cytokine genes in RNA extracted from PBMCs and found no difference in rela-
tive expression of the genes encoding IL-10 and IFNγ among the three groups (Kruskal-Wallis,
il10: p = 0.287; infg: p = 0.619) (Fig 2F and 2G).
Variance of immunological variables was largely attributable to four
components
We wished to determine whether a smaller number of underlying factors explained changes in
the immunological and haematological variables measured in this study. We therefore con-
ducted principal component analysis to explore the entire dataset further because this
approach precluded multiple statistical tests to assess correlations between single variables.
Using eleven input variables, we identified four major components, which collectively
accounted for 83.01% of the variability in the dataset (Fig 3A). Based on their loading scores
(Fig 3B, S3 Table), we named the four components ‘pro-inflammatory process’, which was
highly correlated with the concentrations of the major pro-inflammatory cytokines but nega-
tively correlated with IL-10; ‘IL-10/IL-6 process’; ‘lymphoid response’, associated with the lym-
phocyte and serum globulin concentrations; and ‘myeloid response’, characterised by strong
correlations with the concentrations of granulocytes and monocytes. Assessment of the model
revealed adequate sampling (Bartlett’s test of sphericity, p<0.001) and accuracy (Kaiser-
Meyer-Olkin measure 0.388).
We derived the scores for each component for each dog in the study and found that scores
for component 1, the ‘pro-inflammatory process’, were significantly greater in dogs with
IMHA (Fig 4A) whereas scores for the other components were similar between groups (Fig
4B–4D), confirming that the immunophenotype of dogs with IMHA was distinct from that of
dogs with other inflammatory diseases.
Discussion
In this study, we found that the frequency of Tregs in peripheral blood did not differ between
dogs with primary IMHA and other groups, but we found that the concentrations of pro-
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Fig 1. Flow cytometric characterisation of lymphocyte subsets. Peripheral blood samples underwent red blood cell lysis and the
PBMCs were analysed by flow cytometry using the gating strategy shown (A). The proportions (B) and absolute numbers (C)of
regulatory T cells, (D) CD4+ T cells and (E) CD8+ T cells were similar among the different groups of dogs. Groups were compared using
Kruskal-Wallis tests. IMHA: immune-mediated haemolytic anaemia, INF: inflammatory disease, HC: healthy control.
doi:10.1371/journal.pone.0168296.g001
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Fig 2. Cytokine balance in dogs with IMHA. Measurement of cytokines in peripheral blood indicated greater concentrations
of pro-inflammatory cytokines in dogs with IMHA compared to healthy controls (A-D), with similar concentrations of IL-10 among
all three groups (E). The relative expression of il10 (encoding IL-10) (F) and ifng (encoding IFNγ) (G) was similar among groups.
Groups were compared using Kruskal-Wallis tests, with post-hoc pairwise tests. IMHA: immune-mediated haemolytic anaemia,
INF: inflammatory disease, HC: healthy control.
doi:10.1371/journal.pone.0168296.g002
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inflammatory cytokines were greater in dogs with IMHA compared to other groups. After
condensing the number of dimensions in the dataset by principal component analysis, we
identified four major components that accounted for the majority of the variability among the
immunological and haematological variables. Scores for one of these components (positively
correlated with the concentrations of IL-2, CXCL-8, TNFα, neutrophils and monocytes, and
negatively correlated with IL-10) differed significantly between dogs with IMHA and those
with inflammatory diseases, but there was no difference in scores when comparing the other
three components between groups.
Fig 3. Results of principal component analysis (n = 16 dogs). Four variables explained the majority of the variability in the
dataset, as indicated in the scree plot (A). The loading scores represented in the heatmap (B) indicate the strength of correlation,
either positive or negative, between individual variables and the components extracted in this model. Strong positive (>0.5) or
negative (< -0.5) correlations indicate that the variable contributed greatly to the component, whereas weaker correlations indicate
that the variable made little contribution to the component.
doi:10.1371/journal.pone.0168296.g003
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The role of thymic Tregs in development and progression of autoimmune diseases is an
area of intense investigation in experimental models and in human medicine (as reviewed by
Buckner [21]). Presence of functioning Tregs is required to prevent development of autoim-
mune diseases, as demonstrated in mice that have undergone day 3 thymectomy, cannot
express the Foxp3 transcription factor, or have undergone pharmacological depletion of Tregs
after formation of a mature immune system [22–25]. Similarly, development of spontaneous
autoimmune diseases is observed in people with mutations in the gene encoding FOXP3,
resulting in a group of diseases described as immunodysregulation polyendocrinopathy enter-
opathy X-linked syndrome (IPEX) [26,27].
In contrast to the findings of our study, the frequency of thymic Tregs in peripheral blood
of people with warm AIHA was lower than that of healthy volunteers [28] in a study that
recruited a similar number of patients as our own investigation. Depletion of Tregs by admin-
istration of an anti-CD25 antibody also resulted in a faster onset and more severe form of dis-
ease in a murine model of IMHA induced by administration of rat erythrocytes [29]. Although
numbers of Tregs in peripheral blood were unaltered in dogs with IMHA, it might have been
more pertinent to investigate relative proportions of regulatory cells in the liver and spleen
because the MPS of these organs is considered to be the principal site of destruction of red
blood cells in affected animals [1]. This strategy has proven to be informative in studies of
rheumatoid arthritis in people, in whom the frequency of Tregs is consistently increased in
synovial fluid [30–32] but may be increased, normal or decreased in peripheral blood when
compared to healthy controls (summarised by Miyara et al, 2011 [33]). To our knowledge, the
Fig 4. Comparison of individual scores for components: Individual scores were derived for each animal for each component.
Scores for the component named the ‘pro-inflamamtory process’ were greater in dogs with IMHA than in those with inflammatory diseases
(A), whereas the scores for the other components were similar between groups (B-D). Scores were compared with Mann-Whitney U tests.
IMHA: immune-mediated haemolytic anaemia, INF: inflammatory disease.
doi:10.1371/journal.pone.0168296.g004
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lymphoid populations of the liver and spleen have yet to be studied in dogs with IMHA, which
is likely to be related to the difficulty in obtaining such samples in living animals.
The functional properties of Tregs also were not evaluated in this study but this is an impor-
tant area for future investigation because changes in suppressive activity could be associated
with development of autoimmune disease, even without changes in the numbers of cells pres-
ent [21]. This notion is supported by studies of people with type 1 diabetes mellitus and multi-
ple sclerosis, in whom the suppressive activity of Tregs was impaired in assays performed in
vitro [34,35].
We investigated the relative frequency and absolute numbers of CD4+FoxP3+ Tregs in this
study because the phenotype and suppressive activity of this population of cells has been char-
acterised extensively in dogs [7,8,36]. However, previous studies indicate that conventional T
helper cells also may be induced to adopt a regulatory Tr1 phenotype in people with AIHA
[37,38]. These Tr1 cells produced IL-10 in response to peptides derived from the immunodo-
minant Rhesus D molecule, such that they were able to suppress production of IFNγ by
PBMCs when cultured together. Preliminary investigations in our own laboratory suggest that
Tr1 cells also may be induced in dogs, though the role of these cells in development of IMHA
has not yet been investigated.
Production of cytokines was investigated using two methods in this study: by direct mea-
surement of the serum concentrations of five cytokines and by quantitative PCR to evaluate
expression of the genes encoding two cytokine genes. These approaches should provide com-
plementary information by defining the nature of the cytokine milieu at the point of diagnosis
and also indicating which cytokines are being produced by PBMCs at the same stage in the
autoimmune response. The results of these assays indicated that development of IMHA was
associated with high serum concentrations of cytokines that are generally considered to have
pro-inflammatory effects, but it is not possible to determine whether these changes were con-
tributing to the development of the disease or whether they occurred in response to the
destruction of red blood cells.
An increased serum concentration of IL-2 has been reported previously in dogs with
IMHA [39] and in people with AIHA [40], and there has been speculation that this abnormal-
ity might be associated with an increased tendency for T cells to proliferate in vitro in the latter
group [41]. According to traditional models, increased concentrations of IL-2, CXCL-8 and
TNFα suggested that the immune response might be driven by Th1 cells, resulting in activa-
tion of phagocytes and other cells capable of clearing intracellular pathogens [42]. The autoim-
mune response in patients with AIHA was previously considered to have a Th1 phenotype
because PBMCs stimulated in vitro with self-antigens were found to produce large amounts of
the signature cytokine IFNγ [37].
Since the discovery of the Th17 subset of helper T cells, it has become increasingly apparent
that several autoimmune diseases are strongly associated with inappropriate Th17 activity
[43]. In people with AIHA, increased frequencies of Th17 cells in peripheral blood and an
increased serum concentration of IL-17 have been observed; the concentration of IL-17 was
also correlated with disease activity [44,45]. Interleukin-17 is also able to cause activation of
phagocytes, resulting in release of CXCL-8, IL-6 and TNFα [46]. This discussion raises the
interesting possibility that IMHA in dogs also could be driven by an autoimmune response
with a Th17 phenotype, resulting in phagocyte activation and production of pro-inflammatory
cytokines. Further characterisation of Th17 responses will be an important area for future
research in dogs with autoimmune diseases.
There was no difference in the serum concentration of IL-10 among groups, nor in the rela-
tive expression of the il10 gene. These results differ from those reported in another study of
IMHA in dogs [39] and from in vitro studies of PBMCs from people with wIMHA [28,47,48],
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in which the concentration of IL-10 was increased in affected individuals. Interleukin 10 is
considered to be an important regulatory cytokine, yet serum concentrations appear to be par-
adoxically high in diseases characterised by production of autoantibodies, including AIHA
and systemic lupus erythematosus (SLE) [49]. In the latter disease, increased IL-10 secretion
permits survival of autoreactive B cells and encourages production of pathogenic antibodies
[50].
We identified several individual dogs, even among those that were considered to be healthy
controls, which had particularly high concentrations of some serum cytokines. It is possible
that some of these dogs had occult inflammatory or immune-mediated diseases, but no diag-
noses had been made by the time the study concluded. Production of these cytokines could
also vary with genetic background, age, sex or neuter status in dogs, as has been reported in
people [51–53]. In addition, inflammatory diseases that are strongly associated with particular
breeds could develop due to abnormalities in the innate immune system, as has been described
in Chinese Shar pei dogs with recurrent fevers caused by overproduction of IL-6 [54].
In an effort to explore our dataset for latent variables, we performed principal component
analysis using haematological and immunological variables. Unsurprisingly, the predominant
component was positively correlated with the pro-inflammatory cytokines (IL-2, CXCL-8 and
TNFα) but negatively correlated with the serum concertation of IL-10, and scores for this com-
ponent differed between groups.
A second but separate component was positively correlated with the serum concentrations
of IL-6 and IL-10, which recalls an interesting notion proposed by other workers that some
autoimmune responses may be driven by an imbalance in the concentrations of these two
cytokines [55]. In particular, studies of mice with experimental autoimmune encephalitis (a
model of human multiple sclerosis) indicated that excessive concentrations of IL-6 interfere
with the action of IL-10, inhibiting the regulatory action of this cytokine on autoreactive B
cells and other components of the innate and adaptive immune system [56]. Interestingly, we
also found that the concentration of IL-6 was significant greater in dogs with IMHA compared
to either healthy controls or dogs with inflammatory diseases, which finding contradicts a pre-
vious study which did not demonstrate a difference in the concentration of this cytokine in
dogs with IMHA compared to healthy controls [39]. In that study, the concentration of IL-6
was below the lower limit of detection in all healthy controls and in at least half of the dogs
with IMHA, which led the authors to speculate that failure to observe the expected difference
could have been related to poor analytical sensitivity.
The final two components appeared to correspond to different types of inflammatory
response, with a third component positively correlated with the lymphocyte count and serum
globulin concentration. This could reflect increased production of immunoglobulin by lym-
phocytes in chronic inflammatory states, even with normal total concentrations of serum glob-
ulin, but we did not undertake serum protein immunoelectrophoresis to test this hypothesis.
The final component was highly correlated with the concentrations of the major leukocytes,
particularly those of the granulocytes and monocytes. We described this component as a ‘mye-
loid response’, and leukocytosis has been noted in a large proportion of dogs and identified as
a negative prognostic indicator in previous studies of IMHA [57–59]. We suspect that this
response is driven by the production of pro-inflammatory cytokines, which are likely to affect
haemopoietic stem cells directly [60], and to result in the extramedullary haemopoiesis that we
have observed often in the livers and spleens of affected dogs.
The difference in the score for the ‘pro-inflammatory process’ between groups highlights
the difference between dogs with IMHA and those included in the inflammatory disease group,
which acted as a positive control group for this study. The difference in concentration of TNFα
among groups indicated that development of IMHA results in a stronger pro-inflammatory
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response than the various inflammatory diseases though we cannot determine, based on this
study, whether this is a direct result of the autoimmune response or related to the host response
to release of damage-associated molecular patterns from disrupted red blood cells.
We chose to conduct principal component analysis to allow us to integrate the data from
multiple parameters and to explore the dataset in a way that would facilitate future investiga-
tions. Whereas this approach avoided multiple individual statistical comparisons and associ-
ated risk of errors, our analysis may have been limited by the small number of individuals
included and the relatively high case-to-variable ratio. Furthermore, the components identified
should not be considered causative factors in the development of disease but rather as statisti-
cal constructs that help to explain the results obtained in this investigation.
This study has a number of additional limitations, largely related to the relatively small
number of cases, whichmay have reduced the power to detect small differences between
groups. With a small number of exceptions, all samples were collected at the point of presenta-
tion of diseased dogs to the study institution. Because the autoimmune response had already
progressed to the point of causing clinical disease by this time and because follow-up samples
were not available, causality could not be ascribed in this study, and the effects of treatment on
the autoimmune response could not be determined. Our study omitted some important fac-
tors that would have helped us to characterise the autoimmune response more completely,
such as the serum concentrations of IL-17 and IFNγ and the frequencies of Th1 and Th17 T
cells, though these are areas of planned investigation.
In conclusion, we found that dogs with IMHA had greater serum concentrations of pro-
inflammatory cytokines than dogs with inflammatory diseases, but there was no difference in
the frequency of Tregs or the regulatory cytokine IL-10. Further investigations will be required
to define the character of the autoimmune response and elucidate possible therapeutic targets,
and to determine whether these immunological changes have any impact on survival.
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